FIELD: veterinary medicine.
SUBSTANCE: method involves a joint application of the Aminoseleton tissue specimen on days 1, 3 and 5 of the treatment course, which is administered subcutaneously in the upper third of the neck at a growing dose of 40-45-50 ml. The immunomodulator is administered in a dose of 10 ml intramuscularly on days 2, 4 and 6 of treatment. Bovine recombinant interferons α and γ are used as an immunomodulator.
EFFECT: method is highly effective for the treatment of subclinical mastitis in lactating cows.
3 tbl, 1 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD OF TREATING SUBCLINICAL MASTITIS IN LACTATING COWS | 2021 | 
 | RU2768609C1 | 
| METHOD FOR THE TREATMENT OF SUBCLINICAL MASTITIS IN LACTATING COWS | 2022 | 
 | RU2783249C1 | 
| METHOD OF TREATMENT OF SUBCLINICAL MASTITIS IN LACTATING COWS | 2013 | 
 | RU2538721C1 | 
| TREATMENT OF MASTITIS IN LACTATING COWS | 2022 | 
 | RU2796986C1 | 
| METHOD OF TREATMENT OF SUBCLINICAL MASTITIS IN LACTATING COWS | 2010 | 
 | RU2441660C1 | 
| METHOD FOR COMPLEX THERAPY OF MASTITIS IN LACTATING COWS | 2020 | 
 | RU2756125C1 | 
| METHOD OF PREVENTION MASTITIS OF LACTATING COWS | 2018 | 
 | RU2683289C1 | 
| METHOD FOR PREVENTING MASTITIS IN LACTATING COWS | 2019 | 
 | RU2731476C1 | 
| PREVENTION OF MASTITIS IN LACTATING COWS | 2023 | 
 | RU2804852C1 | 
| METHOD OF TREATING ACUTE CATARRHAL MASTITIS IN LACTATING COWS | 2024 | 
 | RU2833128C1 | 
Authors
Dates
2017-05-18—Published
2016-11-15—Filed